missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human EGF Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

€ 202.00 - € 561.00

Specifications

Accession Number P01133
For Use With (Application) Bioactivity
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Gene ID (Entrez) 1950
Molecular Weight (g/mol) M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18788816
View Documents
R&D Systems™
236-EG-200
200 μg
€ 202.00
200µg
Please to purchase this item. Need a web account? Register with us today!
18330548
View Documents
R&D Systems™
236-EG-01M
1 mg
€ 561.00
1mg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblast cells. Rubin, J.S. et al. (1991) Proc. Natl. Acad. Sci. USA 88:415. The ED50 for this effect is 20-100 pg/mL.
Specifications

Specifications

P01133
Lyophilized from a 0.2 μm filtered solution in PBS.
M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa
E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met
<0.10 EU / 1 μg of the protein by the LAL method.
Unconjugated
Reconstitute at 500 μg/mL in sterile PBS.
EGF
Bioactivity
1950
EGF
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
EGF
Recombinant
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Videos
SDS
Documents

Documents

Product Certifications